Companies: 10,795·Total market cap: $144.5T
IntelGenx Technologies Corp.

IntelGenx Technologies Corp.

IGXTOTCHealthcare
$0.17
+$0.00(+0.00%)
Market Cap$29691860
P/E Ratio
52W High$0.17
52W Low$0.1593
Overview

IntelGenx Technologies Corp. (IGXT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IGXT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.06igxt eps ttm · igxt earnings per shareEarnings history
PE Ratio (TTM)igxt pe ratio ttm · igxt price to earningsPE Ratio deep dive
Revenue (TTM)$1.1Migxt revenue ttm · igxt annual revenueFull revenue history
Dividend YieldNo Dividenddoes igxt pay dividends · igxt dividend yieldDividend history
Shares Outstanding174.7Migxt shares outstanding · igxt floatShares outstanding history
Next EarningsTBAigxt earnings date · igxt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$1.0M▲ +9.37% YoY
202120222023
intelgenx technologies corp. revenue · igxt revenue 2023
FY 2023Net Income-$9.9M▲ +17.05% YoY
202120222023
intelgenx technologies corp. net income · igxt profit 2023
FY 2023EPS$-0.06▲ +21.76% YoY
202120222023
igxt eps · intelgenx technologies corp. earnings per share 2023
TTM:Revenue: $1.1MNet Income: -$11.0MEPS: $-0.06View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis igxt a buy · igxt analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.17Current
$Avg Target
$High
igxt price target · igxt 12 month forecast

Total: 2 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-20.54%

About IntelGenx Technologies Corp.

CEOTommy Kenny
IPO DateJan 17, 2007
Employees48
CountryCA

IntelGenx Technologies Corp. operates as a specialized drug delivery firm, concentrating on the creation and production of innovative oral thin film products for the pharmaceutical industry. Their cur…

what is intelgenx technologies corp. · igxt stock overview · intelgenx technologies corp. company profile · who is intelgenx technologies corp. ceo · igxt OTC · intelgenx technologies corp. headquarters · intelgenx technologies corp. business segments

About Stock Overview & Key Data

IntelGenx Technologies Corp. (IGXT) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 17, 2007. As of the latest trading session, IGXT stock price is $0.17, with a market capitalization of $29.7M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

According to 2 Wall Street analysts, the consensus rating for IntelGenx Technologies Corp. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, IntelGenx Technologies Corp. reported revenue of $1.0M and net income of -$9.9M. For detailed data — including IntelGenx Technologies Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, IntelGenx Technologies Corp. (IGXT) stock price is $0.17. The stock is traded on OTC under the ticker symbol IGXT. The 52-week range is $0.16 – $0.17.

IGXT stock priceIGXT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice